OC9:F:F-Omnicell Inc (EUR)

COMMON STOCK | Health Information Services |

Last Closing

USD 44.4

Change

0.00 (0.00)%

Market Cap

USD 2.04B

Volume

10.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-02 )

Largest Industry Peers for Health Information Services

Symbol Name Price(Change) Market Cap
L0T:F GE HEALTHCARE TECH.INC.

N/A

USD 37.77B
2HE:F Healthequity Inc

N/A

USD 6.90B
4YC:F M3 INC.

N/A

USD 6.89B
6HL0:F R1 RCM Inc

N/A

USD 5.57B
9EH:F Evolent Health Inc

N/A

USD 2.44B
1KJ:F 10X GENOMICS DL -00001

N/A

USD 1.73B
6JM:F JMDC INC.

N/A

USD 1.69B
1XZ:F Ping An Healthcare and Technol..

N/A

USD 1.55B
4LL:F Teladoc Inc

N/A

USD 1.50B
19P:F Phreesia Inc

N/A

USD 0.98B

ETFs Containing OC9:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Health Information Services) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 26.86% 80% B- 80% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 26.86% 80% B- 80% B-
Trailing 12 Months  
Capital Gain 57.45% 91% A- 86% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 57.45% 91% A- 86% B+
Trailing 5 Years  
Capital Gain -31.69% 45% F 28% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -31.69% 45% F 28% F
Average Annual (5 Year Horizon)  
Capital Gain -1.99% 65% D 38% F
Dividend Return -1.99% 62% D 33% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 58.48% 9% A- 18% F
Risk Adjusted Return -3.40% 65% D 37% F
Market Capitalization 2.04B 92% A 67% D+

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector